NCT02291887View on ClinicalTrials.gov

Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept

CompletedOBSERVATIONAL

Enrollment

13

Participants

Timeline

Start Date

December 22, 2014

Primary Completion Date

July 1, 2015

Study Completion Date

July 1, 2015

Conditions

Age-Related Macular Degeneration

Interventions

DRUG

Ranibizumab

Intravitreal injection of Ranibizumab

DRUG

Aflibercept

Intravitreal injection of Aflibercept

Trial Locations (1)

48073

Associated Retinal Consultants, Royal Oak

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Associated Retinal Consultants, Michigan

OTHER